219 related articles for article (PubMed ID: 26949444)
1. Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells.
Byrne SM; Church GM
Curr Protoc Stem Cell Biol; 2015; 35(Suppl 35):5A.8.1-5A.8.22. PubMed ID: 26949444
[TBL] [Abstract][Full Text] [Related]
2. Genome editing in human stem cells.
Byrne SM; Mali P; Church GM
Methods Enzymol; 2014; 546():119-38. PubMed ID: 25398338
[TBL] [Abstract][Full Text] [Related]
3. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
4. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
5. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
Zhu Z; González F; Huangfu D
Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas-mediated targeted genome editing in human cells.
Yang L; Mali P; Kim-Kiselak C; Church G
Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
[TBL] [Abstract][Full Text] [Related]
7. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
Hendriks WT; Jiang X; Daheron L; Cowan CA
Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
[TBL] [Abstract][Full Text] [Related]
8. Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.
Yang Y; Zhang X; Yi L; Hou Z; Chen J; Kou X; Zhao Y; Wang H; Sun XF; Jiang C; Wang Y; Gao S
Stem Cells Transl Med; 2016 Jan; 5(1):8-19. PubMed ID: 26676643
[TBL] [Abstract][Full Text] [Related]
9. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
10. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
12. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.
Pu J; Frescas D; Zhang B; Feng J
Exp Biol Med (Maywood); 2015 Aug; 240(8):1065-70. PubMed ID: 25956682
[TBL] [Abstract][Full Text] [Related]
13. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
14. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
Dettmer R; Naujok O
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
[TBL] [Abstract][Full Text] [Related]
15. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.
Liang X; Potter J; Kumar S; Zou Y; Quintanilla R; Sridharan M; Carte J; Chen W; Roark N; Ranganathan S; Ravinder N; Chesnut JD
J Biotechnol; 2015 Aug; 208():44-53. PubMed ID: 26003884
[TBL] [Abstract][Full Text] [Related]
16. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system.
Li S; Xue H; Long B; Sun L; Truong T; Liu Y
J Vis Exp; 2015 May; (99):e52539. PubMed ID: 26065872
[TBL] [Abstract][Full Text] [Related]
17. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
18. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
[TBL] [Abstract][Full Text] [Related]
19. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
20. Fast and Efficient Generation of Isogenic Induced Pluripotent Stem Cell Lines Using Adenine Base Editing.
Nami F; Ramezankhani R; Vandenabeele M; Vervliet T; Vogels K; Urano F; Verfaillie C
CRISPR J; 2021 Aug; 4(4):502-518. PubMed ID: 34406036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
